Drug Type Small molecule drug |
Synonyms 4-methoxy-N-[3-(2-pyridinyl)isoquinolin-1-yl]benzamidine |
Target |
Mechanism A3R antagonists(Adenosine A3 receptor antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |